KATHERINE WERNER: Open Payments
NPI 1730734922 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,158 in 118 payments from 27 companies in 2025. Trend: 2023 $2,174 · 2024 $2,200 · 2025 $3,158
Food & beverage: $3,038Education: $100Consulting: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $401 |
| GlaxoSmithKline, LLC. | 26 | $396 |
| GENZYME CORPORATION | 13 | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $263 |
| Octapharma USA, Inc. | 5 | $239 |
| Organon LLC | 4 | $200 |
| Lilly USA, LLC | 2 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $126 |
| Galderma Laboratories, L.P. | 2 | $112 |
| Blueprint Medicines Corporation | 4 | $105 |
Products named: DUPIXENT, NUCALA, VTAMA, AIRSUPRA, AYVAKIT, EBGLYSS, PANZYGA, FASENRA.
Industry payments across AZ — which companies pay providers there.
